STAK
Stak·NASDAQ
--
--(--)
--
--(--)
3.91 / 10
Netural
Fundamental health is subdued with a comprehensive score of 3.9/10. Key concerns include a significant year-over-year profit decline (-320.1149%) and negative net cash flow to total liabilities ratio (-0.2078%), indicating liquidity pressure. However, EBIT margin (-23.3417) and net profit share (100%) are in better groups, providing some balance. The view remains guarded.
Analysis Checks(1/4)
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score1/3
Weight27.20%
1M Return2.61%
Value100.00
Score1/3
Weight27.20%
1M Return2.61%
Net cash flow from operating activities / Total liabilities (%)
Value-0.21
Score0/3
Weight-2.40%
1M Return-0.26%
Value-0.21
Score0/3
Weight-2.40%
1M Return-0.26%
Total profit (YoY growth rate %)
Value-320.11
Score1/3
Weight19.02%
1M Return1.77%
Value-320.11
Score1/3
Weight19.02%
1M Return1.77%
EBIT / Total operating revenue (%)
Value-23.34
Score3/3
Weight56.18%
1M Return4.86%
Value-23.34
Score3/3
Weight56.18%
1M Return4.86%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score1/3
Weight27.20%
1M Return2.61%
Value100.00
Score1/3
Weight27.20%
1M Return2.61%
Total profit (YoY growth rate %)
Value-320.11
Score1/3
Weight19.02%
1M Return1.77%
Value-320.11
Score1/3
Weight19.02%
1M Return1.77%
Net cash flow from operating activities / Total liabilities (%)
Value-0.21
Score0/3
Weight-2.40%
1M Return-0.26%
Value-0.21
Score0/3
Weight-2.40%
1M Return-0.26%
EBIT / Total operating revenue (%)
Value-23.34
Score3/3
Weight56.18%
1M Return4.86%
Value-23.34
Score3/3
Weight56.18%
1M Return4.86%
Is STAK undervalued or overvalued?
- STAK scores 3.91/10 on fundamentals and holds a Fair valuation at present. Backed by its -48.66% ROE, -22.93% net margin, 2.10 P/E ratio, 0.46 P/B ratio, and -320.83% earnings growth, these metrics solidify its Netural investment rating.
